This study used a APPswe/PS1dE9 (APP/PS1) double transgenic mouse model, which is extensively used for the study of biochemical and pathological mechanisms as well as exploring therapeutic treatments of AD [12]. This evidence concerns the gene APP and Alzheimer disease.